Evidence map›Paper›PMID 42346094›Full record

ArticleCells2026

Generation of Functional Oligodendrocyte Progenitor Cells Through Serial Replating of iPSC-Derived NPC Spheres.

Junmyeong Park, Seungye Kang, Soojin Kim, Donghyun Kim, Borami Shin, Ji Young Mun, Yurim Park, Johnny Kim, Steven A Goldman, Kee-Pyo Kim

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Junmyeong ParkDepartment of Medical Life Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
Seungye KangDepartment of Medical Life Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
Soojin KimDepartment of Medical Life Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
Donghyun KimDepartment of Medical Life Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.
Borami ShinDepartment of General Pediatrics, University of Children's Hospital Muenster, Albert-Schweitzer-Campus 1, Gebäude A1, 48149 Münster, Germany.
Ji Young MunNeural Circuits Research Group, Korea Brain Research Institute (KBRI), 61 Cheomdan-ro, Dong-gu, Daegu 41062, Republic of Korea.
Yurim ParkNeural Circuits Research Group, Korea Brain Research Institute (KBRI), 61 Cheomdan-ro, Dong-gu, Daegu 41062, Republic of Korea.
Johnny KimThe Center for Cardiovascular Regeneration and Immunology at TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg-University Mainz gGmbH, Freiligrathstraße 12, 55131 Mainz, Germany.ORCID 0000-0002-5226-5460
Steven A GoldmanCenter for Translational Neuromedicine, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642, USA.
Kee-Pyo KimDepartment of Medical Life Sciences, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Republic of Korea.ORCID 0000-0002-8666-8444

Funding

Government of the Republic of Korea RS-2025-02305102Government of the Republic of Korea RS-2026-25521782Ministry of Health and Welfare 26-BR-06-01Ministry of Health and Welfare RS-2025-16068032Ministry of Health and Welfare RS-2025-16068430Ministry of Science and ICT 26-BR-06-01
6 · The paper itself

Abstract

Oligodendrocytes (OLs) are essential for myelin formation in the central nervous system, and their loss or dysfunction is a hallmark of various demyelinating and neurodegenerative disorders. Although oligodendrocyte precursor cells (OPCs) represent a promising cell source for remyelination therapies, existing protocols for generating OPCs from human-induced pluripotent stem cells (iPSCs) are often limited by prolonged culture duration, low efficiency, and cellular heterogeneity. Here, we report an efficient and reproducible platform for generating OPCs from iPSC-derived neural progenitor cells (iNPCs) through stage-specific modulation of developmental signaling pathways. Directed differentiation of iNPCs recapitulated key developmental transitions, progressing through OLIG2

Indexed as

Induced Pluripotent Stem CellsNeural Stem CellsOligodendrocyte Precursor CellsOligodendrogliaSpheroids, CellularAnimalsCell DifferentiationHumansMiceMyelin SheathiPSCsneural progenitor cellsoligodendrocyte progenitor cellsoligodendrocytes

Identifiers

PMID42346094
PMCPMC13297427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.